ADRs End Higher; Sasol Declines

International stocks trading in New York closed higher on Monday.

Sasol Ltd. (SSL, SOL.JO) was among the companies with ADRs that traded actively.

The BNY Mellon index of American depositary receipts rose 0.7% to 125.30. The European index increased 0.5% to 123.88; the Asian index improved 1.2% to 133.16; the Latin American index rose 0.6% to 173.62; and the emerging markets index increased 0.5% to 230.36.

Sasol's ADRs fell 11% to $28.60 after the South Africa industrial chemical producer said it expects its per-share earnings to decline 10% to 30% for the fiscal year ending June 30.

HSBC Holdings PLC (HSBC, HSBA.LN, 0005.HK) pushed out some senior bankers in a restructuring of its investment banking business. The changes come after HSBC in February formed a new global banking division and hired former Goldman Sachs executive Matthew Westerman to co-head it with Robin Phillips. HSBC is the latest bank to change its investment banking business to reduce costs and try to make more money from clients across the group. ADRs fell 4 cents to $32.50.

French drug giant Sanofi (SNY, SAN.FR) and U.S. partner Regeneron Pharmaceuticals (REGN) said a one-year phase three trial study showed a treatment combining their drug dupilumab with topical corticosteroids significantly improved the situations of a group of patients suffering from atopic dermatitis. Sanofi's ADRs rose 2 cents to $41.16.

Write to Tess Stynes at [e-mail]

(END) Dow Jones Newswires

June 06, 2016 17:10 ET (21:10 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.